{
  "docId": "019de077-2ede-72aa-ade1-9df6586a5c43",
  "docSlug": "07da8690ded5d079d6760889d2f598d8",
  "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 31,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "team_bio",
  "function": "other",
  "density": "overcrowded",
  "nDataPoints": 7,
  "notes": "Includes corporate structure details, shareholder list, and headshots of leadership.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/22",
  "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43",
  "deckJsonHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43.json",
  "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.5,
        "x": 0.45,
        "y": 0.62
      },
      "kind": "image",
      "text": "Board of Directors headshots",
      "attrs": null,
      "subkind": "headshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d88f246-bc27-4bf3-860a-91d5d72c00a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.5,
        "x": 0.45,
        "y": 0.23
      },
      "kind": "image",
      "text": "Leadership team headshots",
      "attrs": null,
      "subkind": "headshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc47a274-7230-40dd-9c8d-4094e230d171",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.05,
        "y": 0.83
      },
      "kind": "image",
      "text": "Strategic/partnership shareholders: Lilly, AstraZeneca",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d4c248b4-6800-4e17-8c9a-70e12d715d51",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "list",
      "text": "Key Shareholders (July '24): Ken Mulvany (co-founder) - 26.7% Temasek Life Sciences - 14.8% Zaoui - 7.1% (Odyssey sponsors) Ally Bridge Group - 6.7% Link - 6.6% Lansdowne Partners - 4.5% Schroders - 3.8%",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "51f4b359-d034-4e21-b5ba-427e36168fb0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.35,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "paragraph",
      "text": "COMPANY INFORMATION Listed on EuroNext; April 2022 (Euronext Amsterdam: BAI) Offices in London and laboratories in Cambridge UK c.180 employees",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c20a4fe-14ad-4bb2-90ee-4ad21851d0a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.43,
        "y": 0.17
      },
      "kind": "title",
      "text": "Revitalised leadership for innovation and growth",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "285404c2-a973-42a1-9ce6-7b547a883f98",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.5,
        "x": 0.43,
        "y": 0.53
      },
      "kind": "title",
      "text": "Supported by an experienced Board of Directors at the forefront of their fields...",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f85d013-7175-4c2e-8aae-d799d0d82522",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.55,
        "x": 0.43,
        "y": 0.03
      },
      "kind": "title",
      "text": "BenevolentAI: Leading AI innovations in Drug Discovery and Development",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7eeac932-f41b-48cb-8829-3e43b88186d9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "9e5c4779-1383-445a-b026-d5a13d3e532c",
      "evidence": "Key Shareholders (July '24): Ken Mulvany (co-founder) - 26.7% Temasek Life Sciences - 14.8% Zaoui - 7.1% (Odyssey sponsors) Ally Bridge Group - 6.7% Link - 6.6% Lansdowne Partners - 4.5% Schroders - 3.8%",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}